These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25420906)

  • 21. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
    Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
    Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
    Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J
    Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells.
    Lin Y; Xu T; Teng H; Cui M
    Int J Clin Exp Pathol; 2015; 8(9):10061-71. PubMed ID: 26617713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.
    Sun J; Fan Z; Lu S; Yang J; Hao T; Huo Q
    Int J Mol Med; 2016 Feb; 37(2):485-92. PubMed ID: 26743688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.
    Wu L; Hui H; Wang LJ; Wang H; Liu QF; Han SX
    Oncol Rep; 2015 May; 33(5):2309-18. PubMed ID: 25760058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo.
    Liu J; Dong BF; Wang PS; Ren PY; Xue S; Zhang XΝ; Han Z; Chen G
    Oncol Rep; 2015 Mar; 33(3):1551-9. PubMed ID: 25592304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1.
    Liu K; Chen H; You Q; Ye Q; Wang F; Wang S; Zhang S; Yu K; Li W; Gu M
    Int J Oncol; 2018 Jul; 53(1):257-265. PubMed ID: 29749434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1).
    Zhou J; Xu T; Yan Y; Qin R; Wang H; Zhang X; Huang Y; Wang Y; Lu Y; Fu D; Chen J
    PLoS One; 2013; 8(7):e68469. PubMed ID: 23869222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.
    Chen W; Niu S; Ma X; Zhang P; Gao Y; Fan Y; Pang H; Gong H; Shen D; Gu L; Zhang Y; Zhang X
    PLoS One; 2016; 11(7):e0157599. PubMed ID: 27384222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA-binding protein QKI-5 inhibits the proliferation of clear cell renal cell carcinoma via post-transcriptional stabilization of RASA1 mRNA.
    Zhang RL; Yang JP; Peng LX; Zheng LS; Xie P; Wang MY; Cao Y; Zhang ZL; Zhou FJ; Qian CN; Bao YX
    Cell Cycle; 2016 Nov; 15(22):3094-3104. PubMed ID: 27767378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of COUP-TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cells.
    Zheng J; Qin W; Jiao D; Ren J; Wei M; Shi S; Xi W; Wang H; Yang AG; Huan Y; Wen W
    Int J Cancer; 2016 Oct; 139(7):1574-85. PubMed ID: 27193872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00037 Inhibits Proliferation of Renal Cell Carcinoma Cells in an Epidermal Growth Factor Receptor-Dependent Way.
    Gong X; Du X; Xu Y; Zheng W
    Cell Physiol Biochem; 2018; 45(2):523-536. PubMed ID: 29393141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
    Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
    Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive nin one binding protein expression predicts poor outcome in prostate cancer.
    Chen J; Wang J; Cui X; Liu Y; Yin L; Li Y; Chen L; Xu D; Gao Y
    Mol Med Rep; 2015 Apr; 11(4):2671-6. PubMed ID: 25503472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.